Oceania Healthcare's (NZSE:OCA) Earnings Are Of Questionable Quality

Oceania Healthcare Limited (NZSE:OCA) announced strong profits, but the stock was stagnant. We did some digging, and we found some concerning factors in the details.

View our latest analysis for Oceania Healthcare

earnings-and-revenue-history
NZSE:OCA Earnings and Revenue History May 31st 2024
Advertisement

The Impact Of Unusual Items On Profit

To properly understand Oceania Healthcare's profit results, we need to consider the NZ$48m gain attributed to unusual items. While it's always nice to have higher profit, a large contribution from unusual items sometimes dampens our enthusiasm. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. And that's as you'd expect, given these boosts are described as 'unusual'. Oceania Healthcare had a rather significant contribution from unusual items relative to its profit to March 2024. As a result, we can surmise that the unusual items are making its statutory profit significantly stronger than it would otherwise be.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Oceania Healthcare's Profit Performance

As we discussed above, we think the significant positive unusual item makes Oceania Healthcare's earnings a poor guide to its underlying profitability. For this reason, we think that Oceania Healthcare's statutory profits may be a bad guide to its underlying earnings power, and might give investors an overly positive impression of the company. But the happy news is that, while acknowledging we have to look beyond the statutory numbers, those numbers are still improving, with EPS growing at a very high rate over the last year. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. So while earnings quality is important, it's equally important to consider the risks facing Oceania Healthcare at this point in time. When we did our research, we found 2 warning signs for Oceania Healthcare (1 is potentially serious!) that we believe deserve your full attention.

Today we've zoomed in on a single data point to better understand the nature of Oceania Healthcare's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NZSE:OCA

Oceania Healthcare

Owns and operates retirement villages and care centres in New Zealand.

Undervalued with questionable track record.

Advertisement

Weekly Picks

TA
Talos
TSLA logo
Talos on Tesla ·

The "Physical AI" Monopoly – A New Industrial Revolution

Fair Value:US$665.3637.3% undervalued
25 users have followed this narrative
14 users have commented on this narrative
17 users have liked this narrative
MA
CSG logo
Marek_Trnka on CSG ·

Czechoslovak Group - is it really so hot?

Fair Value:€5547.0% undervalued
35 users have followed this narrative
1 users have commented on this narrative
13 users have liked this narrative
AL
alex30free
SECARE logo
alex30free on Swedencare ·

The Compound Effect: From Acquisition to Integration

Fair Value:SEK 46.2846.5% undervalued
9 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

RE
PROX logo
RecMag on Proximus ·

Proximus: The State-Backed Backup Plan with 7% Gross Yield and 15% Currency Upside.

Fair Value:€2567.1% undervalued
37 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
CO
Coward_Nutlick
ELTX logo
Coward_Nutlick on Elicio Therapeutics ·

Very Bullish

Fair Value:US$10091.6% undervalued
12 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
DM
DMXS
EEE logo
DMXS on Coca-Cola HBC ·

A Tale of Two Engines: Coca-Cola HBC (EEE.AT)

Fair Value:€576.1% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

DA
davidlsander
UBI logo
davidlsander on Ubisoft Entertainment ·

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

Fair Value:€33.887.8% undervalued
57 users have followed this narrative
5 users have commented on this narrative
25 users have liked this narrative
OO
NEO logo
OOO97 on Neo Performance Materials ·

Undervalued Key Player in Magnets/Rare Earth

Fair Value:CA$25.3319.7% undervalued
79 users have followed this narrative
0 users have commented on this narrative
20 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0226.1% undervalued
1067 users have followed this narrative
6 users have commented on this narrative
32 users have liked this narrative

Trending Discussion

Advertisement